Anastasia Voitovich

Quell Therapeutics

Poster(s):

• Tu154 - Use of Engineered CAR-Treg Cells to Induce Immune Tolerance in Liver Transplantation – Insights from the LIBERATE Clinical Trial
  Tuesday, June 24, 2025

  6:00pm - 7:30pm East Coast USA Time